Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Plexus Corp(PLXS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PLXS
10/13/2026: PLXS (3-star) is a REGULAR-BUY. BUY for 9 days. Simulated Profits (-4.61%). Updated daily EoD!
Plexus Corp is a specialized electronics manufacturing services provider that focuses on complex, high-reliability products for the healthcare, industrial, and aerospace sectors. The company differentiates itself through an integrated design and manufacturing model that appeals to customers requiring rigorous quality standards. Its main growth opportunity lies in increasing outsourcing trends among medical and industrial clients, though the business is susceptible to customer concentration risks and manufacturing sector volatility. The stock is best suited for growth-oriented investors who prioritize long-term partnership models over dividends. Monitoring key program ramps and global supply chain stability remains critical for assessing the company’s future execution and performance in its niche market.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company benefits from long-term secular growth trends in medical and industrial outsourcing. |
| Momentum investor | Mixed fit | Momentum depends on the specific timing of new program launches and market cycles. |
| Value investor | Mixed fit | The stock valuation typically reflects its high-quality niche positioning rather than deep-value metrics. |
| Dividend investor | Weak fit | Plexus does not currently offer a dividend, making it unsuitable for income-focused portfolios. |
| Low-risk investor | Mixed fit | While established, the stock is subject to manufacturing sector volatility and customer concentration risks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock can experience price swings tied to industrial sector cycles. |
| Valuation risk | Medium | Market sentiment toward manufacturing multiples can impact P/E ratios. |
| Competition risk (EMS sector) | High | Intense pricing pressure from larger players like Jabil can impact margins. |
| Business quality | Medium | The company has a strong reputation for quality in complex markets. |
| Dividend income | Low / none | There is no current dividend payout. |
| Execution risk | Medium | Success depends on the efficient ramp-up of complex manufacturing programs. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 36.59% | Avg. Invested days 48 | Today’s Advisory Regular Buy |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/13/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 6.87B USD | Price to earnings Ratio 38.08 | 1Y Target Price 304.6 |
Price to earnings Ratio 38.08 | 1Y Target Price 304.6 | ||
Volume (30-day avg) 216.4K shares | Beta 0.89 | 52 Weeks Range 132.03 - 307.06 | Updated Date 10/13/2026 |
52 Weeks Range 132.03 - 307.06 | Updated Date 10/13/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 6.77 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Healthcare/Life Sciences | Design and build for medical devices and diagnostic equipment. | Steady revenue source from essential, high-margin medical equipment manufacturing. |
| Industrial/Commercial | Manufacturing of advanced automation and machinery. | Strong growth potential driven by global automation trends. |
| Aerospace/Defense | High-reliability electronic assemblies. | Highly stable, contract-based revenue in a secure industry. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 38.08 | Forward PE 24.15 | Enterprise Value 6.53B | Price to Sales(TTM) 1.49 |
Enterprise Value 6.53B | Price to Sales(TTM) 1.49 | ||
Enterprise Value to Revenue 1.42 | Enterprise Value to EBITDA 21.46 | Shares Outstanding 26.65M | Shares Floating 26.27M |
Shares Outstanding 26.65M | Shares Floating 26.27M | ||
Percent Insiders 1.43 | Percent Institutions 104.28 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.